Life Sciences

As industry momentum continues, oligonucleotide manufacturers are making the leap from benchtop production to commercial scale. The challenges of large-scale oligo manufacturing, however, are exponential in comparison to small scale, lab-based operations.

Precision medicine is based on the idea that each of us is different and may not react the same way to a particular treatment.

Developers are facing an opportunity and a dilemma: Competition is at an all-time high in the life sciences industry, which means companies must create work environments that attract and retain top researchers, encourage collaboration and innovation all while maintaining a flexible space that can evolve to meet new research demands and technology.

How do classic plasma fractionation separation methods compare? And what comes next?

Facing pressure in the ATMP marketplace? Multimodal manufacturing is your solution for that.

Here’s the thing we figured out about offering a single solution, though: when you try to fit everyone, you wind up fitting no one.

As part of a broad strategy to accelerate the response to the global pandemic of COVID-19, the government has been selecting the most promising manufacturing candidates and providing coordinated government support to scale up production capacity immediately—Operation Warp Speed (OWS).

The animal health market is changing. These four strategies will help your facility change with it.